Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAF312 in Postoperative Dental Pain
NCT00986882Phase 2Completed
- Sponsor
- Novartis
- Start
- Sep 2009
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SAF312 in odontalgia, sponsored by Novartis. Started Sep 2009; status: completed.
02
Drugs
SAF312
03
Conditions
odontalgia
Beyond the preview
Go deeper on NCT00986882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00986882.